Contact your healthcare provider promptly if you experience: Repeated or persistent vomiting An inability to keep food or fluids down Dizziness, reduced urination, or very dark urine Severe or persistent abdominal pain Abdominal pain that radiates toward the back Significant abdominal swelling Severe constipation An inability to pass stool or gas Worsening nausea or diarrhea Symptoms that make it difficult to eat or drink Digestive symptoms that continue despite meal adjustments Vomiting and diarrhea can lead to dehydration
Why orforglipron wont be for everyone Currently, there is only one GLP-1 pill on the market: Novo Nordisks Rybelsus, an oral form of its blockbuster drug semaglutide (the active ingredient in Ozempic and Wegovy) thats approved to treat type 2 diabetes
From there, the researchers tested 100 peptides they knew or suspected could affect the brains hunger drive (including GLP-1 for comparison)
Medical Disclaimer: This chart is for informational and reference purposes only
Any changes in color, the presence of particles, or cloudiness indicate that the medication may have degraded and should not be used
The reported distribution of causes of death for this cohort included: CVD (36%) Cancer (32%) Natural Causes (25%) Other/suicide/accidents (6%) 4 While the authors didnt investigate the association between cause of death and POP chemicals, there is substantial human and animal evidence linking POP exposure to mortality from both cardiovascular disease (CVD) and cancer, which were the two most common causes of death in this study.29,30 Moreover, the study population was derived from Finland, a country with several known POP toxicity risk hotspots